Literature DB >> 18209602

Recreational all-terrain vehicle injuries among children: an 11-year review of a Central Kentucky level I pediatric trauma center database.

Blakely Kute1, John A Nyland, Craig S Roberts, Vicki Hartwick-Barnes.   

Abstract

BACKGROUND: A database review of 238 admissions for recreational all-terrain vehicle (ATV) accident-related injuries treated over an 11-year period at a level I pediatric trauma center in Central Kentucky was performed.
METHODS: Descriptive statistical analysis of patient demographics (age and sex), helmet use, county of residence, county of ATV accident, injury mechanism, injuries sustained, days of hospitalization, days in the intensive care unit, Glasgow Coma Scale (GCS) score, Injury Severity Score, Functional Independence Measure (FIM) score, and discharge disposition was performed.
RESULTS: All-terrain vehicle accident-related admissions increased approximately 4.7 times, and overall fracture number increased 4 times over the study period. Most injuries were sustained in the county of residence (81.1% [193 of 238]). The single largest group of patients resided and sustained injuries (48.3% [115 of 238]) in a level I county (metropolitan area population, > or =1 million). Mean Injury Severity Score was 7.3 +/- 5.6, and average hospitalization was 4.3 +/- 4.0 days. Most patients (84% [201 of 238]) were not wearing a helmet, and 18.1% (43 of 238) were admitted to the intensive care unit. Patients were aged 11.4 +/- 3.6 years, predominantly boys (70% [166 of 238]), between the age of 11 and 15 years (59.7% [142 of 238]), and 63% (150 of 238) sustained at least 1 fracture. The lower extremity (32.4% [66 of 204]), upper extremity (25% [51 of 204]), and face-skull (25% [51 of 204]) were the most common fracture sites. The femur (45.5% [30 of 66]) and tibia-fibula (42.4% [28 of 66]) were the most common lower extremity fracture sites. The radius-ulna (39.2% [20 of 51]) and humerus (25% [13 of 51]) were the most common upper extremity fracture sites. Nine patients (4.4% of total fractures) sustained spinal fractures. Most patients (93.7% [223 of 238]) were discharged home, 6.3% (15 of 238) were discharged to a rehabilitation facility or to another hospital. Helmet use was related to higher component GCS and FIM communication scores, and patients with higher component GCS and FIM scores were more likely discharged to home.
CONCLUSIONS: Hospital admissions and fractures concurrently increased over the study period, with the greatest increase occurring between 1998 and 1999, shortly after expiration of the 1988 Consent Decrees between the Consumer Product Safety Commission and the ATV industry.

Entities:  

Mesh:

Year:  2007        PMID: 18209602     DOI: 10.1097/bpo.0b013e31815a60c4

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  4 in total

1.  Imaging findings in 512 children following all-terrain vehicle injuries.

Authors:  Chetan C Shah; Raghu H Ramakrishnaiah; Sadaf T Bhutta; Donna N Parnell-Beasley; Bruce S Greenberg
Journal:  Pediatr Radiol       Date:  2009-03-24

2.  Pediatric all-terrain vehicle (ATV) injuries: An epidemic of cost and grief.

Authors:  Kent A Strohecker; Christian J Gaffney; Jove Graham; Kaan Irgit; Wade R Smith; Thomas R Bowen
Journal:  Acta Orthop Traumatol Turc       Date:  2017-07-10       Impact factor: 1.511

3.  Epidemiology and factors associated with all-terrain vehicle accidents in children: A retrospective cross-sectional study of a trauma registry in Saudi Arabia.

Authors:  Mohammed Al Mutari; Bushra Alasmari; Lama Aldosari; Rahaf Alluhaidan; Reham Aljohani; Shahd Omar Hijazi; Fatmah Othman
Journal:  Int J Crit Illn Inj Sci       Date:  2021-12-18

4.  Traumatic Spinal Injury Associated with All-Terrain Vehicle (ATV) Accidents: A 10-Year Retrospective Analysis of the Coachella Valley.

Authors:  Brian Fiani; Rebecca Houston; Alessandra Cathel; Elisabeth Pennington; Imran Siddiqi; Mohammad Arshad; Marisol Soula; Ryne Jenkins
Journal:  Korean J Neurotrauma       Date:  2021-08-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.